1 unchanged sentence
Market Information
−Removed: Our common stock has been listed on the Nasdaq Global Market under the symbol “RPHM” since April 9, 2021.
−Removed: Prior to that date, there was no public market for our common stock.
−Removed: Holders of Common Stock
−Removed: As of March 26, 2024, there were 33,420,808 shares of our common stock outstanding held by approximately 184 holders of record of our common stock.
+Added: Our Class A common stock has been listed on The Nasdaq Global Market under the symbol “OKUR” since October 7, 2024.
+Added: From April 9, 2021 through October 4, 2024, our common stock was listed on the Nasdaq Global Market under the symbol “RPHM”.
+Added: As of March 7, 2025, there were 12,749,299 shares of our Class A common stock outstanding held by approximately 59 holders of record of our Class A common stock and there were 686,527 shares of our Class B common stock outstanding held by 1 holder of record of our Class B common stock.
The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.
2 unchanged sentences
We intend to retain future earnings, if any, to finance the operation of our business and do not anticipate paying any cash dividends in the foreseeable future.
−Removed: Any future determination related to dividend policy will be made at the discretion of our Board of Directors and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects and other factors our Board of Directors may deem relevant.
+Added: Any future determination related to dividend policy will be made at the discretion of our Board and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects and other factors our Board may deem relevant.
Securities Authorized for Issuance Under Equity Compensation Plans
2 unchanged sentences
Except as previously reported in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the Securities and Exchange Commission ("SEC") during the year ended December 31, 2024, there were no unregistered sales of equity securities by us during the year ended December 31, 2024.
−Removed: Purchases of Equity Securities by the Issuer and Affiliated Purchasers
−Removed: On October 30, 2023, pursuant to a Common Stock Repurchase Agreement with vTv Therapeutics, we repurchased 576,443 shares of our common stock from vTv Therapeutics at a price of $7.64 per share for an aggregate purchase price of approximately $4.4 million in a private, non-underwritten transaction.
−Removed: Subsequently, we retired the repurchased shares.
Stock Performance Graph
1 unchanged sentence
Use of Proceeds
−Removed: We commenced our IPO pursuant to the registration statement on Form S-1 (File No.
−Removed: 333‑254534) that was declared effective on April 8, 2021 and registered an aggregate of 7,187,500 shares of our common stock.
−Removed: On April 13, 2021, we completed our IPO and sold 6,250,000 shares of our common stock at a public offering price of $15.00 per share for aggregate gross proceeds of $93.8 million before deducting underwriters’ discounts and
−Removed: commissions and offering-related expenses.
+Added: On April 8, 2021, our registration statement on Form S-1 (File No.
+Added: 333‑254534) relating to our initial public offering (“IPO”) was declared effective.
+Added: On April 13, 2021, we completed our IPO and sold 6,250,000 shares of our common stock at a public offering price of $15.00 per share for aggregate gross proceeds of $93.8 million, before deducting underwriters’ discounts and commissions and offering-related expenses.
Net proceeds, after deducting underwriting discounts and commissions of $6.6 million and offering expenses of approximately $2.6 million, were $84.6 million.
1 unchanged sentence
acted as joint book-running managers.
−Removed: As of December 31, 2023, we have used approximately $46.4 million of the net proceeds from our IPO.
−Removed: We have invested the remaining net proceeds in highly liquid money market funds and short-term investments.
−Removed: The remaining net proceeds from the IPO will be used to fund our operations.
None of the offering proceeds were paid directly or indirectly to any of our directors or officers (or their associates) or persons owning 10.0% or more of any class of our equity securities or to any other affiliates.
+Added: As of December 31, 2024, we have used all of the net proceeds from our IPO.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.